126097006: Ethinylestradiol (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Sex hormone (substance)\Substance with estrogen receptor agonist mechanism of action (substance)\Ethinylestradiol
\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Ethinylestradiol
\Substance categorized by disposition\Receptor agonist\Substance with estrogen receptor agonist mechanism of action (substance)\Ethinylestradiol

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Sex hormone (substance)\Substance with estrogen receptor agonist mechanism of action (substance)\Ethinylestradiol

\Steroid hormone\Ethinylestradiol

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid (substance)\...

\Norsteroid\Ethinylestradiol

\Estrane\Estradiol and/or estradiol derivative\Ethinylestradiol

\Steroid hormone\Ethinylestradiol

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ethinylestradiol	Is a	Norsteroid	true	Inferred relationship	Some
Ethinylestradiol	Is a	estrogen	false	Inferred relationship	Some
Ethinylestradiol	Is a	Syntetisk steroid	false	Inferred relationship	Some
Ethinylestradiol	Is a	kombineret kontraceptivum til oral anvendelse	false	Inferred relationship	Some
Ethinylestradiol	Is a	Estradiol	false	Inferred relationship	Some
Ethinylestradiol	Is a	kontraceptivum til oral anvendelse	false	Inferred relationship	Some
Ethinylestradiol	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Estrogen	false	Inferred relationship	Some
Ethinylestradiol	Is a	Estrane	false	Inferred relationship	Some
Ethinylestradiol	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Estradiol	false	Inferred relationship	Some
Ethinylestradiol	Is a	Estradiol and/or estradiol derivative	true	Inferred relationship	Some
Ethinylestradiol	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Gonadal hormone	false	Inferred relationship	Some
Ethinylestradiol	Is a	Substance with estrogen receptor agonist mechanism of action (substance)	true	Inferred relationship	Some
Ethinylestradiol	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Estrogen receptor agonist	true	Inferred relationship	Some
Ethinylestradiol	Is a	Steroid hormone	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Mestranol	Is a	False	Ethinylestradiol	Inferred relationship	Some
Product containing quinestrol (medicinal product)	Is a	False	Ethinylestradiol	Inferred relationship	Some
Mestranol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing quinestrol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Ethinyloestradiol adverse reaction	Causative agent	True	Ethinylestradiol	Inferred relationship	Some	1
Allergy to ethinylestradiol	Causative agent	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol [endocrine]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 10 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 50 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol [malignancy]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinyl estradiol 50micrograms tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinyl estradiol 20micrograms tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 0,05 mg + levonorgestrel 0,25 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 0,035 mg + norethindron 0,5 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 20 µg + norethindronacetat 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 30 µg + norethindronacetat 1,5 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 50 microgram and norgestrel 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
norelgestromin 6 mg + ethynylestradiol 0,75 plaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol 35 µg + norethisteron 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol + gestoden + placebo /75 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol 20 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol 30 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35mcg+progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol 50 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
gestoden + ethinylestradiol flerfase p-pille	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
P-pille, bifasisk flerfasepræparat (ethinylestradiol + norethisteron)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
desogestrel 0,15 mg + ethynylestradiol 0,01 mg + ethynylestradiol 0,01 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
desogestrel 0,15 mg + ethynylestradiol 0,03 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 50 microgram and etynodiol diacetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol+drospirenone 30micrograms/3mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinyl estradiol + levonorgestrel 0.15mg/0.03mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol 30 µg + drospirenon 3 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 600 µg + norelgestromin 6 mg depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol and norelgestromin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
ethynylestradiol 2,7 mg + etonogestrel 11,7 mg vaginalring	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Quinestrol (substance)	Is a	False	Ethinylestradiol	Inferred relationship	Some
Cervical ripening with ethinyl oestradiol	Direct substance	False	Ethinylestradiol	Inferred relationship	Some	1
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol and norgestimate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Product containing ethinylestradiol and norethisterone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Product containing desogestrel and ethinylestradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
ethynylestradiol + ethynodioldiacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol and levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Norethindron + ethinylestradiol + ferrofumarat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Aranelle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol and norgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Lutera 28 tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 600 µg + norelgestromin 6 mg depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing drospirenone and ethinylestradiol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Drospirenone 2 mg and estradiol 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethynylestradiol 0,02 mg + norelgestromin 0,15 mg pr. dag depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
bivirkning af cyproteronacetat og ethinylestradiol	Causative agent	False	Ethinylestradiol	Inferred relationship	Some	1
allergi over for cyproteronacetat og ethinylenestradiol	Causative agent	False	Ethinylestradiol	Inferred relationship	Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
cyproteronacetat + ethinylestradiol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing ethinylestradiol and gestodene (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ethinylestradiol	Inferred relationship	Some	1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
ethinylestradiol + norethindronacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 35 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Cervical ripening with ethinyl oestradiol	Direct substance	True	Ethinylestradiol	Inferred relationship	Some	1
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ethinylestradiol	Inferred relationship	Some
Allergy to ethinylestradiol	Causative agent	True	Ethinylestradiol	Inferred relationship	Some	1

Page 1 of 4 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2153823018	Ethinylestradiol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2154830016	Ethinyl estradiol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3482238011	Ethinylestradiol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4892521000005119	ethinylestradiol	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)